{"log_id": 2635235404185671369, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 0.004837, "average": 0.977409, "min": 0.581371}, "location": {"width": 837, "top": 189, "height": 36, "left": 211}, "words": "增加2.3%,而与维生素E合用时增加10.9。与维生素C或维生素E合用时无需调整剂量"}, {"probability": {"variance": 0.00027, "average": 0.985267, "min": 0.955658}, "location": {"width": 177, "top": 229, "height": 26, "left": 213}, "words": "强CYP3A4诱导剂"}, {"probability": {"variance": 1.8e-05, "average": 0.998202, "min": 0.974995}, "location": {"width": 808, "top": 259, "height": 32, "left": 256}, "words": "利福平:在一项对16名健康成人男性志愿者进行的研究中,评价了利福平对利奈唑胺"}, {"probability": {"variance": 1.8e-05, "average": 0.997894, "min": 0.979873}, "location": {"width": 446, "top": 297, "height": 27, "left": 210}, "words": "的药代动力学影响。研究中志愿者口服利奈唑胺"}, {"probability": {"variance": 1e-06, "average": 0.998887, "min": 0.99596}, "location": {"width": 359, "top": 291, "height": 34, "left": 705}, "words": "g每日2次共5剂,伴或不伴利福平"}, {"probability": {"variance": 0.011007, "average": 0.964917, "min": 0.475306}, "location": {"width": 814, "top": 329, "height": 30, "left": 244}, "words": "mg每日1次共8天。利福平和利奈唑胺合用,导致利奈唑胺的Cmax降低21%[90%Cl"}, {"probability": {"variance": 0.01269, "average": 0.955298, "min": 0.493311}, "location": {"width": 852, "top": 360, "height": 35, "left": 212}, "words": "5%-27%],AUCo12降低32%[90%C1,27%-37%]。这一相互作用的临床意义不明。这一相互"}, {"probability": {"variance": 5e-06, "average": 0.998886, "min": 0.988194}, "location": {"width": 834, "top": 393, "height": 34, "left": 209}, "words": "作用的机制未完全阐明,可能与肝酶诱导有关。其它肝酶强诱导剂(如卡马西平、苯妥英"}, {"probability": {"variance": 2e-06, "average": 0.998997, "min": 0.995161}, "location": {"width": 368, "top": 431, "height": 25, "left": 211}, "words": "苯巴比妥),可能引起相似或稍轻的变化"}, {"probability": {"variance": 2.9e-05, "average": 0.995656, "min": 0.981589}, "location": {"width": 194, "top": 463, "height": 28, "left": 211}, "words": "单胺氧化酶抑制作用"}, {"probability": {"variance": 1.1e-05, "average": 0.997972, "min": 0.988418}, "location": {"width": 817, "top": 492, "height": 33, "left": 251}, "words": "利奈唑胺为可逆的、非选择性的单胺氧化酶抑制剂。所以,利奈唑胺与肾上腺素能药物"}, {"probability": {"variance": 0.000908, "average": 0.991551, "min": 0.871088}, "location": {"width": 345, "top": 529, "height": 27, "left": 208}, "words": "或5-羟色胺类制剂有潜在的相互作用"}, {"probability": {"variance": 3e-06, "average": 0.998697, "min": 0.994685}, "location": {"width": 173, "top": 596, "height": 28, "left": 209}, "words": "肾上腺素能类药物"}, {"probability": {"variance": 3e-06, "average": 0.998965, "min": 0.9917}, "location": {"width": 819, "top": 624, "height": 33, "left": 249}, "words": "有些患者接受利奈唑胺可能使非直接作用的拟交感神经药物、血管加压药或多巴胺类药"}, {"probability": {"variance": 6.2e-05, "average": 0.997613, "min": 0.949749}, "location": {"width": 850, "top": 657, "height": 33, "left": 207}, "words": "物的加压作用可逆性地增加。已对其与常用的药物如苯丙醇胺和伪麻黄碱的作用进行了研究"}, {"probability": {"variance": 1e-06, "average": 0.999384, "min": 0.993684}, "location": {"width": 863, "top": 690, "height": 33, "left": 207}, "words": "肾上腺素能类药物,如多巴胺或肾上腺素的起始剂量应减小,并逐步调整至可起理想药效的"}, {"probability": {"variance": 0, "average": 0.999765, "min": 0.999544}, "location": {"width": 44, "top": 728, "height": 25, "left": 206}, "words": "水平"}, {"probability": {"variance": 6.1e-05, "average": 0.997369, "min": 0.954112}, "location": {"width": 822, "top": 753, "height": 35, "left": 248}, "words": "酪胺:当健康成人受试者同时接受利奈唑胺及超过100mg的酪胺时,可见明显的增压反"}, {"probability": {"variance": 3e-06, "average": 0.999035, "min": 0.99044}, "location": {"width": 642, "top": 789, "height": 28, "left": 206}, "words": "应。所以,应用利奈唑胺的患者应避免食用酪胺含量高的食物或饮料"}, {"probability": {"variance": 6e-06, "average": 0.998626, "min": 0.987918}, "location": {"width": 820, "top": 819, "height": 33, "left": 250}, "words": "盐酸伪麻黄碱或盐酸苯丙醇胺:对血压正常的健康志愿者给予利奈唑胺,可观察到利奈"}, {"probability": {"variance": 7e-06, "average": 0.998513, "min": 0.986365}, "location": {"width": 860, "top": 852, "height": 30, "left": 204}, "words": "唑胺能可逆性地增加伪麻黄碱(PSE)、盐酸苯丙醇胺(PPA)的增压作用(见【注意事项】"}, {"probability": {"variance": 9.2e-05, "average": 0.996987, "min": 0.938585}, "location": {"width": 865, "top": 884, "height": 34, "left": 205}, "words": "中的药物相互作用)。未对高血压患者进行类似的研究。对血压正常的健康志愿者进行了利奈"}, {"probability": {"variance": 7e-06, "average": 0.997961, "min": 0.989323}, "location": {"width": 870, "top": 917, "height": 33, "left": 203}, "words": "唑胺、PSE、PPA、安慰剂分别单用,及利奈唑胺达稳态时(600mg,每12小时一次,连用3"}, {"probability": {"variance": 0.001504, "average": 0.986971, "min": 0.744637}, "location": {"width": 867, "top": 948, "height": 36, "left": 203}, "words": "天)联用PSE或PPA(PPA,25mg或PSE,60mg各二个剂量,给药间隔4小时)对血压和"}, {"probability": {"variance": 2.8e-05, "average": 0.997304, "min": 0.970977}, "location": {"width": 868, "top": 982, "height": 32, "left": 203}, "words": "心率的影响的研究。任何给药方式心率均不受影响。利奈唑胺与PPA或PSE联用均能使血压"}, {"probability": {"variance": 0.000372, "average": 0.992782, "min": 0.903535}, "location": {"width": 870, "top": 1014, "height": 32, "left": 203}, "words": "上升。在PPA或PSE第二次给药后的2-3小时,观察到最高的血压值;在达峰值后的2-3"}, {"probability": {"variance": 0.000113, "average": 0.997526, "min": 0.930204}, "location": {"width": 872, "top": 1045, "height": 34, "left": 201}, "words": "小时,血压又回复到了基础水平。PPA研究结果表明:平均(范围)最大收缩压以mmHg表"}, {"probability": {"variance": 0.005562, "average": 0.971869, "min": 0.603088}, "location": {"width": 842, "top": 1080, "height": 30, "left": 201}, "words": "示为:安慰剂=121(103—158),利奈唑胺单用=120(107-135);PPA单用=125(106"}, {"probability": {"variance": 0.004141, "average": 0.984129, "min": 0.590259}, "location": {"width": 855, "top": 1111, "height": 30, "left": 217}, "words": "9),PPA与利奈唑胺联用=147(129—176)。PSE的研究结果与PPA的研究结果相似。当"}, {"probability": {"variance": 8e-05, "average": 0.996256, "min": 0.956337}, "location": {"width": 871, "top": 1144, "height": 33, "left": 201}, "words": "利奈唑胺与PSE或PPA联用时,较基础收缩压的平均最大增加值分别为32mmHg(范围:20"}, {"probability": {"variance": 0.010398, "average": 0.97454, "min": 0.456941}, "location": {"width": 433, "top": 1182, "height": 26, "left": 228}, "words": "2mmHg)和38mmHg(范围:18-79mmHg)"}, {"probability": {"variance": 0.000742, "average": 0.987007, "min": 0.915438}, "location": {"width": 153, "top": 1214, "height": 25, "left": 199}, "words": "5-羟色胺类药物"}, {"probability": {"variance": 4e-06, "average": 0.999079, "min": 0.988755}, "location": {"width": 828, "top": 1240, "height": 35, "left": 243}, "words": "右美沙芬:对健康志愿者进行了利奈唑胺与右美沙芬潜在药物相互作用的研究。给予志"}, {"probability": {"variance": 2e-05, "average": 0.997281, "min": 0.979687}, "location": {"width": 875, "top": 1275, "height": 32, "left": 197}, "words": "愿者右美沙芬(二个剂量,20mg每次,间隔4小时),同时给予或不给予利奈唑胺。在接受"}, {"probability": {"variance": 6e-06, "average": 0.998357, "min": 0.989353}, "location": {"width": 875, "top": 1308, "height": 32, "left": 197}, "words": "右美沙芬和利奈唑胺的血压正常的志愿者中未观察到5羟色胺综合征的作用(意识模糊、极"}, {"probability": {"variance": 0, "average": 0.999521, "min": 0.998006}, "location": {"width": 476, "top": 1343, "height": 28, "left": 196}, "words": "度兴奋、不安、震颤、潮红、发汗以及体温升高)"}, {"probability": {"variance": 1e-06, "average": 0.998909, "min": 0.997423}, "location": {"width": 120, "top": 1410, "height": 28, "left": 202}, "words": "【药物过量】"}, {"probability": {"variance": 4e-06, "average": 0.998809, "min": 0.99137}, "location": {"width": 831, "top": 1438, "height": 34, "left": 242}, "words": "在过量事件中,建议应用支持疗法,维持肾小球的滤过。血液透析能加速利奈唑胺的清"}, {"probability": {"variance": 1.1e-05, "average": 0.998472, "min": 0.982169}, "location": {"width": 879, "top": 1472, "height": 33, "left": 194}, "words": "除。在期临床研究中,给予利奈唑胺3小时后,通过3小时的血液透析,30%剂量的药物"}, {"probability": {"variance": 0.009505, "average": 0.966519, "min": 0.440665}, "location": {"width": 878, "top": 1504, "height": 32, "left": 194}, "words": "被清除。尚无腹膜透析或血液滤过清除利奈唑胺的资料。当分别给予3000mg/kg天和"}, {"probability": {"variance": 0.006838, "average": 0.977495, "min": 0.497706}, "location": {"width": 876, "top": 1537, "height": 36, "left": 194}, "words": "2000mg/kg/天的利奈唑胺时,动物急性中毒的临床症状为大鼠活动力下降和运动失调,狗出"}, {"probability": {"variance": 5e-06, "average": 0.998436, "min": 0.993664}, "location": {"width": 132, "top": 1577, "height": 24, "left": 194}, "words": "现呕吐和颤抖"}, {"probability": {"variance": 2e-06, "average": 0.998844, "min": 0.995831}, "location": {"width": 152, "top": 1631, "height": 24, "left": 556}, "words": "第18页,共29页"}, {"probability": {"variance": 0.006864, "average": 0.921328, "min": 0.796732}, "location": {"width": 115, "top": 1659, "height": 20, "left": 573}, "words": "辉瑞——机密"}, {"probability": {"variance": 0.000118, "average": 0.991587, "min": 0.963569}, "location": {"width": 73, "top": 1686, "height": 18, "left": 287}, "words": "20160525"}], "language": 3}